BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 16510480)

  • 1. Ecstasy use and self-reported depression, impulsivity, and sensation seeking: a prospective cohort study.
    de Win MM; Schilt T; Reneman L; Vervaeke H; Jager G; Dijkink S; Booij J; van den Brink W
    J Psychopharmacol; 2006 Mar; 20(2):226-35. PubMed ID: 16510480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Emotion regulation among psychostimulants drug users at techno parties].
    Lillaz C; Varescon I
    Encephale; 2012 Oct; 38(5):390-6. PubMed ID: 23062452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recreational ecstasy use and depression.
    Guillot C; Greenway D
    J Psychopharmacol; 2006 May; 20(3):411-6. PubMed ID: 16574715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K; Turner JJ; Parrott AC
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impulsivity as a predictor of newly diagnosed depression.
    Granö N; Keltikangas-Järvinen L; Kouvonen A; Virtanen M; Elovainio M; Vahtera J; Kivimäki M
    Scand J Psychol; 2007 Apr; 48(2):173-9. PubMed ID: 17430370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.
    de Win MM; Jager G; Booij J; Reneman L; Schilt T; Lavini C; Olabarriaga SD; den Heeten GJ; van den Brink W
    Brain; 2008 Nov; 131(Pt 11):2936-45. PubMed ID: 18842607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impulsivity, risk taking and recreational 'ecstasy' (MDMA) use.
    Butler GK; Montgomery AM
    Drug Alcohol Depend; 2004 Oct; 76(1):55-62. PubMed ID: 15380289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways to ecstasy use in young adults: anxiety, depression or behavioural deviance?
    Alati R; Kinner SA; Hayatbakhsh MR; Mamun AA; Najman JM; Williams GM
    Drug Alcohol Depend; 2008 Jan; 92(1-3):108-15. PubMed ID: 17850992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability.
    Zimmermann P; Wittchen HU; Waszak F; Nocon A; Höfler M; Lieb R
    Drug Alcohol Depend; 2005 Sep; 79(3):331-41. PubMed ID: 15913921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users.
    de Win MM; Reneman L; Jager G; Vlieger EJ; Olabarriaga SD; Lavini C; Bisschops I; Majoie CB; Booij J; den Heeten GJ; van den Brink W
    Neuropsychopharmacology; 2007 Feb; 32(2):458-70. PubMed ID: 17077812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.
    Huxster JK; Pirona A; Morgan MJ
    J Psychopharmacol; 2006 Mar; 20(2):281-90. PubMed ID: 16510486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self reported sleep quality and cognitive performance in ecstasy users.
    Montgomery C; Fisk JE; Wareing M; Murphy P
    Hum Psychopharmacol; 2007 Dec; 22(8):537-48. PubMed ID: 17960556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood - are there gender differences?
    Hoshi R; Pratt H; Mehta S; Bond AJ; Curran HV
    J Psychopharmacol; 2006 Mar; 20(2):291-301. PubMed ID: 16510487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
    Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eating attitudes, weight concerns and beliefs about drug effects in women who use ecstasy.
    Curran HV; Robjant K
    J Psychopharmacol; 2006 May; 20(3):425-31. PubMed ID: 16574717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine use in schizophrenia and disinhibition.
    Dervaux A; Baylé FJ; Laqueille X; Bourdel MC; Le Borgne MH; Olié JP; Krebs MO
    Psychiatry Res; 2004 Oct; 128(3):229-34. PubMed ID: 15541779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced intensity dependence and aggression history indicate previous regular ecstasy use in abstinent polydrug users.
    Wan L; Baldridge RM; Colby AM; Stanford MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1484-90. PubMed ID: 19703509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impulsivity but not venturesomeness is related to morningness.
    Caci H; Mattei V; Baylé FJ; Nadalet L; Dossios C; Robert P; Boyer P
    Psychiatry Res; 2005 Apr; 134(3):259-65. PubMed ID: 15892985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescent ecstasy use and depression: cause and effect, or two outcomes of home environment?
    McCann M; Higgins K; Perra O; McCartan C; McLaughlin A
    Eur J Public Health; 2014 Oct; 24(5):845-50. PubMed ID: 24891459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers.
    Matthews AJ; Bruno R
    Neuropsychobiology; 2010; 61(4):215-22. PubMed ID: 20389132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.